908 DEVICES INC. Debt Securities, Available-for-sale, Unrealized Loss
908 DEVICES INC. (MASS) reported Debt Securities, Available-for-sale, Unrealized Loss of $41.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss · last filed 2026-08-11
- 908 DEVICES INC. debt securities, available-for-sale, unrealized loss for the quarter ending 2025-06-30 was $14.00K.
- 908 DEVICES INC. debt securities, available-for-sale, unrealized loss for the quarter ending 2025-03-31 was $16.00K, a 6.67% increase year-over-year.
- 908 DEVICES INC. debt securities, available-for-sale, unrealized loss for the quarter ending 2024-03-31 was $15.00K.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss 3 month | Debt Securities, Available-for-sale, Unrealized Loss 6 month |
|---|---|---|
| 2026-06-30 | $41.00K 10-Q · filed 2026-08-11 | |
| 2025-06-30 | $14.00K 10-Q · filed 2025-08-05 | $30.00K derived: sum of 2 quarters · filed 2025-08-05 |
| 2025-03-31 | $16.00K 10-Q · filed 2025-08-05 | |
| 2024-03-31 | $15.00K 10-Q · filed 2025-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |